文摘
Front Cover: A reducible branched polyethylenimine (rBPEI)-based nanoparticle (NP) system is introduced as a siRNA carrier to corneal neovascularization therapy. The rBPEI-NPs are efficiently degraded into LMW BPEI inside the cytosol to facilitate a release of siRNA targeting NFkB. Eventually, a significant anti-angiogensis effect without noticeable toxicity is shown. Further details can be found in the article by Hyounkoo Han, Sohee Son, Sejin Son, Namho Kim, Ji Young Yhee, Jae Hyeop Lee, Jun-Sub Choi, Choun-Ki Joo, Hohyeon Lee, Duhwan Lee, Won Jong Kim, Sun Hwa Kim, Ick Chan Kwon, Hyuncheol Kim, and Kwangmeyung Kim on page 1583.